89bio, Inc

YTD

ALL

Why Robinhood?

You can watch 89bio, Inc and buy or sell other stocks, ETFs, and their options commission-free!

About ETNB

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.

CEO

Rohan Palekar

CEORohan Palekar

Employees

Employees93

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2018

Founded2018

Employees

Employees93

ETNB Key Statistics

Market cap

2.20B

Market cap2.20B

Price-Earnings ratio

-4.12

Price-Earnings ratio-4.12

Dividend yield

—

Dividend yield—

Average volume

8.67M

Average volume8.67M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$15.06

52 Week high$15.06

52 Week low

$4.16

52 Week low$4.16

People also own

Based on the portfolios of people who own ETNB. This list is generated using Robinhood data, and it’s not a recommendation.